Novel pyrrolidine compounds that are potent and selective inhibitors of PDE4, as well as methods of making the same, are disclosed. Use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system (CNS) disorders, also is disclosed.
本发明公开了一种具有很高选择性和抑制PDE4活性的新型
吡咯烷化合物,以及其制备方法。还公开了该化合物在治疗炎症性疾病和其他涉及细胞因子
水平升高的疾病,以及中枢神经系统(CNS)疾病中的应用。